The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both ...
Last week, the U.S. Food and Drug Administration (FDA) approved the first generic version of liraglutide injection, a game-changing development that promises to improve patient access to life ...
On January 22, 2025, Medexus was informed that the FDA approved GRAFAPEXâ„¢, an alkylating agent, with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation ...